
HD · NYSE
The supplied consensus is Buy across 31 analysts, with targets ranging from $310 to $497 and a mean of $385. The range is unusually wide: Oppenheimer is identified as the least bullish at $310, while Wolfe Research is the most bullish at $497. The available evidence does not show a clear net revision direction during the past week. UBS reiterated Buy with a $420 target, and Stifel reiterated Hold, leaving the cited opinions unchanged. The substantive disagreement is whether Home Depot’s depressed valuation and potential professional-market recovery outweigh slower demand, weaker returns on capital, SRS execution risk and the possibility that a low multiple reflects structural rather than temporary pressure.
| Firm | Analyst | Rating | Price Target | Upside | Date | Source |
|---|---|---|---|---|---|---|
| Oppenheimer | — | $310 | -0.3% | May 18, 2026 | Open the report this row came from | |
| Wolfe Research | — | $497 | +59.9% | Sep 18, 2025 |